Connection
Mark Nehler to Hypoglycemic Agents
This is a "connection" page, showing publications Mark Nehler has written about Hypoglycemic Agents.
|
|
Connection Strength |
|
 |
|
 |
|
0.094 |
|
|
|
-
Matthews DR, Li Q, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Desai M, Hiatt WR, Nehler M, Fabbrini E, Kavalam M, Lee M, Neal B. Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program. Diabetologia. 2019 06; 62(6):926-938.
Score: 0.094